Class I HLA

Novel Targeting Techniques to Treat Breast, Ovarian and Other Drug Resistant Cancers Set to Start Phase I Clinical Trials in 2015

Over the past several years, researchers in the pharmaceutical industry have complained of a dearth of novel drug targets. … [Read more...]